Davenport & CO LLC Amgen Inc Transaction History

Davenport & CO LLC

$16 Billion
Q2 2024

A detailed history of Davenport & CO LLC transactions in Amgen Inc stock. As of the latest transaction made, Davenport & CO LLC holds 59,780 shares of AMGN stock, worth $19.9 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

59,780

Previous 56,834 5.18%

Holding current value

$19.9 Million

Previous $16.2 Million 15.59%

% of portfolio

0.12%

Previous 0.1%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$262.75 - $319.31 $774,061 - $940,687	2,946 Added 5.18%	59,780 $18.7 Million
Q1 2024 May 03, 2024	SELL	$268.87 - $324.56 $454,390 - $548,506	-1,690 Reduced 2.89%	56,834 $16.2 Million
Q4 2023 Jan 23, 2024	SELL	$255.7 - $288.46 $1.35 Million - $1.52 Million	-5,264 Reduced 8.25%	58,524 $16.9 Million
Q3 2023 Oct 17, 2023	BUY	$218.65 - $271.46 $211,434 - $262,501	967 Added 1.54%	63,788 $17.1 Million
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $1.33 Million - $1.57 Million	6,204 Added 10.96%	62,821 $13.9 Million
Q1 2023 Apr 27, 2023	BUY	$225.79 - $275.2 $595,182 - $725,427	2,636 Added 4.88%	56,617 $13.7 Million
Q4 2022 Jan 20, 2023	SELL	$229.03 - $291.01 $1.36 Million - $1.72 Million	-5,926 Reduced 9.89%	53,981 $0
Q3 2022 Oct 11, 2022	BUY	$224.46 - $253.15 $882,352 - $995,132	3,931 Added 7.02%	59,907 $13.5 Million
Q2 2022 Jul 18, 2022	SELL	$230.71 - $256.74 $397,282 - $442,106	-1,722 Reduced 2.98%	55,976 $13.6 Million
Q1 2022 May 02, 2022	BUY	$219.27 - $242.57 $399,071 - $441,477	1,820 Added 3.26%	57,698 $14 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $189,333 - $216,675	-952 Reduced 1.68%	55,878 $12.6 Million
Q3 2021 Oct 14, 2021	BUY	$212.27 - $248.7 $1.61 Million - $1.89 Million	7,589 Added 15.41%	56,830 $12.1 Million
Q2 2021 Jul 28, 2021	SELL	$233.58 - $259.14 $1.3 Million - $1.44 Million	-5,563 Reduced 10.15%	49,241 $12 Million
Q1 2021 Apr 28, 2021	BUY	$221.91 - $258.6 $1.15 Million - $1.35 Million	5,202 Added 10.49%	54,804 $13.6 Million
Q4 2020 Jan 13, 2021	BUY	$216.38 - $257.67 $623,174 - $742,089	2,880 Added 6.16%	49,602 $11.4 Million
Q3 2020 Oct 15, 2020	SELL	$234.65 - $260.95 $577,942 - $642,719	-2,463 Reduced 5.01%	46,722 $11.9 Million
Q2 2020 Jul 28, 2020	BUY	$197.81 - $242.74 $97,915 - $120,156	495 Added 1.02%	49,185 $11.6 Million
Q1 2020 May 05, 2020	SELL	$182.24 - $241.7 $84,559 - $112,148	-464 Reduced 0.94%	48,690 $9.87 Million
Q4 2019 Jan 22, 2020	SELL	$189.21 - $243.2 $217,213 - $279,193	-1,148 Reduced 2.28%	49,154 $11.9 Million
Q3 2019 Oct 16, 2019	SELL	$174.11 - $208.62 $31,339 - $37,551	-180 Reduced 0.36%	50,302 $9.27 Million
Q2 2019 Jul 10, 2019	BUY	$166.7 - $195.41 $492,265 - $577,045	2,953 Added 6.21%	50,482 $9.3 Million
Q1 2019 Apr 17, 2019	SELL	$180.87 - $203.88 $213,788 - $240,986	-1,182 Reduced 2.43%	47,529 $9.03 Million
Q4 2018 Jan 28, 2019	BUY	$178.4 - $208.25 $73,144 - $85,382	410 Added 0.85%	48,711 $9.48 Million
Q3 2018 Oct 11, 2018	BUY	$185.29 - $208.89 $583,478 - $657,794	3,149 Added 6.97%	48,301 $10 Million
Q2 2018 Jul 09, 2018	SELL	$166.05 - $186.51 $29 Million - $32.5 Million	-174,370 Reduced 79.43%	45,152 $8.34 Million
Q1 2018 Apr 04, 2018	SELL	$169.43 - $198.0 $391,891 - $457,974	-2,313 Reduced 1.04%	219,522 $37.4 Billion
Q4 2017 Jan 17, 2018	SELL	$168.79 - $188.59 $746,895 - $834,510	-4,425 Reduced 1.96%	221,835 $38.6 Billion
Q3 2017 Oct 12, 2017	BUY	$167.29 - $191.0 $37.9 Million - $43.2 Million	226,260	226,260 $42.2 Billion

Others Institutions Holding AMGN

# of Institutions

3,054

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $178B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davenport & CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Davenport & CO LLC with notifications on news.

Account